Clinical Significance of Serial Measurement of the Serum Levels of Soluble Interleukin-2 Receptor and Soluble CD8 in Malignant Lymphoma

References

• Rubin L. A., Nelson D. L. The soluble interleu-kin-2 receptor: biology, function, and clinical application. Ann. Intern. Med. 1990; 113: 619–627
   PubMed Web of Science ®Google Scholar
• Zerler B. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells 1991; 3: 471–479
   PubMed Web of Science ®Google Scholar
• Motoi T., Uchiyama T., Uchino H., Ueda R., Araki K. Serum soluble interleukin-2 receptor levels in patients with adult T-cell leukemia and human T-cell leukemia/lymphoma virus type-I seropositive healthy carriers. Jpn. J. Cancer Res. 1988; 79: 593–599
   PubMedGoogle Scholar
• Yamaguchi K., Nishimura Y., Kiyokawa T., Takat-Suki K. Elevated serum levels of soluble interleukin-2 receptors in HTLV-I-associated myelopathy. J. Lab. Clin. Med. 1989; 114: 407–410
   PubMedGoogle Scholar
• Cimino G., Annino L., Giona F., Sgadari C., Di G. A., Cava M. C., Cimino G., Mandelli F. Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia. Leukemia 1991; 5: 602–605
   PubMed Web of Science ®Google Scholar
• Lauria F., Rondelli D., Raspadori D., Zinzani P. L., Ben-Fenati D., Pileri S., Sabattini E., Tura S. Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment. Leukemia and Lymphoma 1992; 7: 103–107
   PubMed Web of Science ®Google Scholar
• Gause A., Roschansky V., Tschiersch A., Smith K., Has-Enclever D., Schmits R., Diehl V., Pfreundschuh M. Low serum interleukin-2 receptor levels correlate with a good prognosis in patients with Hodgkin's lymphoma. Ann. Oncol. 1991; 2: 43–47
   PubMed Web of Science ®Google Scholar
• Gause A., Jung W., Schmits R., Tschiersch A., Scholz R., Pohl C., Hasenclever D., Diehl V., Pfreundschuh M. Soluble CD8, CD25 and CD30 antigens as prognostic markers in patients with untreated Hodgkin's lymphoma. Ann. Oncol. 1992; 4: 49–52
   Google Scholar
• Semenzato G., Foa R., Agostini C., Zambello R., Tren-Tin L., Vinante F., Benedetti F., Chilosi M., Pizzolo G. High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood 1987; 70: 396–400
   PubMed Web of Science ®Google Scholar
• Musolino C., Di C. E., Alonci A., Allegra A., Orlando A., Grosso P., Squadrito G. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia. Acta Haematol. 1991; 85: 57–61
   PubMed Web of Science ®Google Scholar
• Cacciola E., Calogero D., Marra G., Guglielmo P. Serum levels of soluble interleukin-2 receptor (sIL-2R) in B-chronic lymphocytic leukemia. Boll. Soc. Ital. Biol. Sper. 1992; 68: 259–262
   PubMedGoogle Scholar
• Barak V., Ginzburg M., Kalickman I., Polliack A. Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Leukemia and Lymphoma 1992; 7: 431–438
   PubMed Web of Science ®Google Scholar
• Pavlidis A. N., Kalef E. J., Bourantas L. C., Lambrou A., Mavridis A. Serum tumor markers in non-Hodgkin's lymphomas and chronic lymphocytic leukemia. Int. J. Biol. Markers 1993; 8: 14–20
   PubMedGoogle Scholar
• Pavlidis N. A., Manoussakis M. N., Germanidis G. S., Moutsopoulos H. M. Serum-soluble interleukin-2 receptors in B-cell lymphoproliferative malignancies. Med. Pe-diatr. Oncol. 1992; 20: 26–31
   PubMedGoogle Scholar
• Wagner D. K., Kiwanuka J., Edwards B. K., Rubin L. A., Nelson D. L., Magrath I. T. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation with survival. J. Clin. Oncol 1987; 5: 1262–1274
   PubMed Web of Science ®Google Scholar
• Chang C. S., Lin S. F., Liu H. W. Soluble interleukin-2 receptor levels in patients with non-Hodgkin's lymphoma or with acute leukemia. Chung Hua Min Kuo Wei Sheng Wu Chi Mien 1 Hsueh Tsa Chih 1988; 21: 79–84
   Google Scholar
• Harrington D. S., Patil K., Lai P. K., Yasuda N. N., Ar-Mitage J. O., Ip S. H., Weisenburger D. D., Linder J., Purtilo D. T. Soluble interleukin 2 receptors in patients with malignant lymphoma. Arch. Pathol. Lab. Med. 1988; 112: 597–601
   PubMed Web of Science ®Google Scholar
• Chilosi M., Semenzato G., Vinante F., Menestrina F., Piazzola E., Focchiatti V., Sabbioni R., Zanotti R., Pizzolo G. Increased levels of soluble interleukin-2 receptor in non-Hodgkin's lymphomas. Relationship with clinical, histologic, and phenotypic features. Am. J. Clin. Pathol. 1989; 92: 186–191
   PubMed Web of Science ®Google Scholar
• Tomkinson B. E., Brown M. C., Ip S. H., Carrabis S., Sullivan J. L. Soluble CD8 during T cell activation. J. Immunol. 1989; 142: 2230–2236
   PubMed Web of Science ®Google Scholar
• Agostini C., Semenzato G., Vinante F., Sinicco A., Tren-Tin L., Zambello R., Zuppini B., Zanotti R., Siviero F., Veneri D. Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders. Clin. Immunol. Immunopathol. 1989; 50: 146–153
   PubMedGoogle Scholar
• Semenzato G., Siviero F., Vinante F., Zambello R., Tren-Tin L., Agostini C., Adami F., Vincenzi C., Zanotti R., Zuppini B. Serum levels of soluble CD8 are increased in patients with B chronic lymphocytic leukemia. Eur. J. Cancer Clin. Oncol. 1989; 25: 1577–1581
   PubMedGoogle Scholar
• Saadeh C., Auzenne C., Nelson D., Orson F. Sera from the aged contain higher levels of IL-2 receptor compared to young adults. Fed. Proc 1986; 45: 378
   Google Scholar
• Onji M., Kikuchi T., Kumon I., Masumoto T., Nadano S., Kajino K., Horiike N., Ohta Y. Intrahepatic lymphocyte subpopulations and HLA class I antigen expression by hepatocytes in chronic hepatitis C. Hepatogastroen-terology 1992; 39: 340–343
   PubMed Web of Science ®Google Scholar
• Ginns L. C., De H. A., Brown M. C., Gaumond B. R. Elevated concentration of soluble interleukin-2 receptors in serum of smokers and patients with lung cancer. Correlation with clinical activity. Am. Rev. Respir. Dis. 1990; 142: 398–402
   PubMed Web of Science ®Google Scholar
• Tollerud D. J., Weiss S. T., Leung D. Y. Elevated soluble interleukin-2 receptors in young healthy cigarette smokers: lack of association with atopy or airways hy-perresponsiveness. Int. Arch. Allergy. Appl. Immunol. 1992; 97: 25–30
   Google Scholar